• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume8, Issue3

THE CLINICAL OUTCOME OF BOTULINUM TOXIN TYPE A INJECTION IN CONGENITAL ESOTROPIA : A CASE SERIES

    Arandz Ruttu, Marlyanti NurRahmah , Ratih Natasha Maharani

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 4707-4709

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Botulinum toxin type A (BTX-A) is the precise drug to cause temporary paralysis of extraocular muscles and change ocular alignment with few side effects. Congenital esotropia is an ocular misalignment characterized by a convergent non-accommodative ocular deviation which develops at approximately six months of age. Botulinum toxin type A has been used in congenital esotropia as an alternative treatment to surgery.In this study, we report three cases of large angle congenital esotropiamore than 45 prismdiopter (PD)underwent BTX-A injection simultaneously on both medial rectus muscles. The procedure was done under total intravenous anesthesia (TIVA) with upright position. A unit of BTX-A in 0.1 mililiter was injected through the intact conjunctiva into the medial rectus muscle. Two weeks after injection, two patients developed exotropiaand one patient developed ptosis. Four months after injection, all the cases showed improvement in ocular alignment (less than 35 PD) with no other complication. Botulinum toxin type Ainjection represents a secure alternative procedurein case of congenital esotropia and reduce the angle of deviation before surgical interventions were planned.
Keywords:
    Botulinum toxin congenital esotropia case series
  • PDF (162 K)
  • XML
(2021). THE CLINICAL OUTCOME OF BOTULINUM TOXIN TYPE A INJECTION IN CONGENITAL ESOTROPIA : A CASE SERIES. European Journal of Molecular & Clinical Medicine, 8(3), 4707-4709.
Arandz Ruttu, Marlyanti NurRahmah , Ratih Natasha Maharani. "THE CLINICAL OUTCOME OF BOTULINUM TOXIN TYPE A INJECTION IN CONGENITAL ESOTROPIA : A CASE SERIES". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 4707-4709.
(2021). 'THE CLINICAL OUTCOME OF BOTULINUM TOXIN TYPE A INJECTION IN CONGENITAL ESOTROPIA : A CASE SERIES', European Journal of Molecular & Clinical Medicine, 8(3), pp. 4707-4709.
THE CLINICAL OUTCOME OF BOTULINUM TOXIN TYPE A INJECTION IN CONGENITAL ESOTROPIA : A CASE SERIES. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 4707-4709.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 190
  • PDF Download: 123
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus